
During the past 50 years, clinical trials have led to dramatic improvement in pediatric cancer zzso Prior studies have shown that zzso and age groups have not been enrolled zzso zzso Hispanics, and adolescents are zzso and black children are zzso This study identifies the current zzso representation in pediatric zzso birth to 19 zzso cancer treatment zzso 

The authors compared the observed proportions zzso of US children enrolled in Children's Oncology Group zzso clinical trials from 2000 through 2003 with expected proportions zzso based on zzso zzso and End zzso zzso zzso The zzso were zzso by zzso age, sex, and cancer type zzso or zzso zzso tests and zzso confidence intervals were used for O versus E zzso 

Although representation was fairly zzso for each zzso group, significantly zzso solid tumor zzso were whites zzso zzso adolescents ages 10 to 19 years, and Hispanics aged zzso zzso For zzso zzso significantly zzso zzso were blacks, Hispanics, adolescents ages 10 to 19 years, blacks aged zzso years, Hispanics aged zzso years, white and black zzso and black and Hispanic zzso The most significantly zzso groups were adolescents ages 15 to 19 years for both solid zzso O vs zzso zzso and zzso zzso O vs zzso zzso zzso and Hispanic females with zzso zzso zzso O vs zzso zzso zzso enrolled zzso of expected cancer zzso 

Although zzso groups are zzso represented in zzso trials, some specific zzso including the youngest black and Hispanic children, Hispanic zzso and particularly white adolescents ages 15 to 19 years may be zzso and may benefit from targeted zzso 

